ICE-HBV took part in the World Hepatitis Summit in Sao Paulo on November 1-3, 2017, joining 900 delegates from all over the world. The World Hepatitis Summit is a large-scale, global biennial event to advance the viral hepatitis agenda. It is a joint initiative between World Health Organization (WHO) and the World Hepatitis Alliance – in collaboration with a different host country for each Summit.
Among others news, WHO announced that in 2.8 million additional people starting lifelong treatment for hepatitis B in 2016 was a marked increase from the 1.7 million people starting it in 2015.
ICE-HBV presented a poster and held an international consultation on its scientific priorities and governance systems, attended by delegates from five continents (picture). ICE-HBV was also presented by ANRS as part of the plenary presentation by Prof. Christian Trepo.